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Abstract
Background: Laxatives are efficient drugs, but the effectiveness has been questioned. In nursing homes, the
prevalence of constipation is high and laxatives are commonly used drugs. The aims of the study were to assess
the effectiveness of laxative therapy in an everyday setting in Norwegian nursing homes, study differences
between treatment regimens and factors associated with normal bowel function.
Methods: A cross-sectional study. After giving informed consent, residents above 60 years of age using laxatives
for functional constipation were included, and their characteristics, medical history, use of drugs and bowel
functions were recorded. Normal bowel function was defined as bowel movements from 3 times/week to 3 times/
day and stool consistency 3-5 on Bristol Stool Form Scale.
Results: Out of 647 residents in the nursing homes, 197 were included and 116 (59%) had normal bowel function.
The treatment effect did not differ significantly between the laxatives, treatment regimens or expected efficacy of
the regimens. The treatment was unsatisfactorily adapted to individual needs. In subjects with normal bowel
function, 113 (97%) had persistent complaints; 68 (59.5%), 10 (8.0%), 34 (28.6%) and 26 (22.5%) reported straining,
manual manoeuvre to facilitate bowel movements, feeling of incomplete bowel movements, and feeling of
anorectal obstruction respectively. Good nutritional status, previous or present cancer disease and anxiety/
depression were predictors of normal bowel function.
Conclusions: Treatment of constipation in nursing homes was unsatisfactory. Nearly all patients with normal stool
frequency and consistence had some persistent complaints. Improved nutrition and individualization of the
treatment could improve the outcome.
Background
The prevalence of constipation in nursing homes is up
to 74% and more than half of the residents use laxatives
[1,2]. Constipation is most often a primary or functional
disorder of unknown aetiology associated with gut dys-
motility (slow transit) and pelvic floor dysfunction, but
might be secondary to an organic disease. Symptoms are
infrequent defecations, hard stools, straining, sensation
of incomplete defecation, sensation of anorectal obstruc-
tions, and need for manual manoeuvres to facilitate
bowel movements [3]. After exclusion of organic dis-
eases, these symptoms are the basis for the diagnosis of
functional constipation according to the Rome criteria
[4]. Constipation is a troublesome disorder associated
with reduced quality of life and high costs [2,5,6].
Laxatives are, in addition to conservative interventions
(dietary fibre, physical activity, fluid etc.), the corner-
stone in the treatment of constipation. All groups of
laxatives (osmotic laxatives, stimulant laxatives, enemas/
suppositories, and miscellaneous pharmaceuticals) are
superior to placebo [7]. But in contrast to the overall
good results in clinical trials, patients’ satisfaction with
everyday use of laxatives is low, only 47% were satisfied
in a web-based survey in the general population [8].
Knowledge of the treatment of constipation in frail
elderly is insufficient and the treatment poses extra chal-
lenges in this population [3,9].
T h ea i m so ft h i sc r o s ss e c t i o n a ls t u d yi nn u r s i n g
homes were to asses the effectiveness of laxative therapy
in an everyday setting, study differences between
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with satisfactory effect.
Methods
Study design and methods
In 2008-2009, this cross sectional study was performed
in nursing homes in the counties of Oppland and Hed-
mark, Norway.
Registered and auxiliary nurses completed case report
forms based on information from the participants and
their next of kin and in the medical records. A blood
sample was collected.
Study population
Residents above 60 years of age using laxatives regularly
or on demand and who had stayed in the nursing home
for more than 8 weeks, were eligible for the study.
Patients with known organic gastrointestinal diseases
(malignancy, stenosis/stricture, inflammatory bowel dis-
ease, intestinal resection etc.) that could be related to
constipation and those with a planned discharge within
two weeks were excluded.
Variables
General characteristics
The following variables were recorded: age, gender,
weight, height, smoking habits, use of alcohol, somatic
and psychiatric diseases, mobility (score 0-2: Bedridden
or sitting in a chair, walk indoors, walk outdoors), Katz’
Activity of Daily Living (ADL) (index 0-6: 0 = Very
dependent; 6 = Independent), nutritional status (Mini
Nutritional Assessment (MNA
® ) score 0-30: <17 mal-
nourished, 17-23.5 at risk of malnutrition, 24-30 normal
nutritional status) [10], diet (fibre, number of glasses of
fluid/day, consistency of food (mashed food/soups, bread
without crust, ordinary food)), all use of drugs (registered
according to the Anatomical Therapeutic Chemical Clas-
sification System (ATC) level 5) [11], number of drugs,
and use of one or more drugs with markedly anticholi-
nergic effect (defined as group 3 according to Carnahan
et al) [12]. A blood sample was analysed for haematologi-
cal and biochemical screening (electrolytes, hepatic and
renal diseases, and thyroid function).
Use of laxatives
The use and dosage of laxatives was recorded at ATC-
level 5. Groups of laxatives were defined at ATC-level 4:
osmotically acting laxatives (A06AD); contact laxatives
(A06AB); bulk laxatives (A06AC); enemas (A06AG); and
softeners/emollients (A06AA). The dosage of each laxa-
tive was graded as on demand, regular use standard
dose, and regular use of high dose. High dose was
defined as: liquid paraffin > 15ml/day; bisacodyl >
10mg/day; senna glycosides > 24mg/day; sodium pico
sulphate: > 10 drops (5 mg)/day; lactulose > 30ml/day;
macrogol combinations: > 26.2 (2 sachets); docusate
sodium > 1 supp/day; and laurilsulfate: > 1supp/day. An
overall grading of the laxative effect of the regimens
from low to high was as follows: on demand treatment
only; regular use of only fibre or lactulose; regular use
of only contact laxatives, enemas, polyethylene glycol or
liquid paraffin; and use of at least two laxatives of which
one was used regularly. Proper use of laxatives was
assessed by comparison with generally accepted treat-
ment recommendations [2,13-15].
Bowel function
Defecation frequency (number of stools per day), stool
consistency (Bristol Stool Form Scale score 1-7) [16],
straining, sensation of incomplete evacuation, sensation
of anorectal obstruction/blockade, and manual man-
oeuvres to facilitate bowel movements, were recorded.
Normal bowel function was defined as defecation fre-
quency from three defecations/week to three defeca-
tions/day and stool consistency 3-5 on Bristol Stool
Form Scale.
Statistical analyses
Comparisons between groups were performed with stu-
dent t-test, Mann-Whitney U test, unconditional z-
pooled test for table analyses with small counts (≤
5) [17], exact chi-square and linear-by-linear dependent
on type of variable and normality. Manual backward
logistic regression analyses with a one-by-one stepwise
removal of the least significant variable were performed
with “bowel function” (normal/altered) as dependent
variable. Independent variables were variables with at
least 10 subjects in the smallest group and associated
with bowel function with p ≤ 0.2 in the bivariate ana-
lyses. Since a drug is associated with the disease under
treatment, both the group of drugs and the disease were
included if one of them was associated with bowel func-
tion in the bivariate analyses. The one with the lowest
impact on the outcome in the multivariable analyses
was removed. Age, gender and variables with p < 0.05
were maintained in the equation.
Multiple imputations for missing data were performed
with a model including all principal variables [18]. The
statistical analyses were performed with PASW statistics
18 and StatXact. Two-sided p-values ≤ 0.05 were
regarded as statistically significant.
Ethics
All participants or their next of kin gave informed con-
sent to participate. The study was approved by the
Regional Committee for Medical and Health Research
Ethics, Central Norway and The Norwegian Data
Inspectorate, represented by Privacy Ombudsman for
Research at Oslo University Hospital, Ullevål, and per-
formed in accordance with the Declaration of Helsinki.
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Participants
The study included 197 residents using laxatives regu-
larly or on demand. Figure 1 is a flow chart of the
residents. The mean age of the participants was 85.6
years (sd 6.9; range 67-103 years), 147 (74.6%) were
w o m e n ,1 2 3( 6 2 . 4 % )w e r eu n a b l et og i v ei n f o r m e d
consent, and 109 (53.3%) were bedridden. One hun-
dred and sixteen (58.9%) had normal bowel function.
Table 1 gives the characteristics of the participants in
more detail. Three residents with gastro-intestinal can-
cer were excluded.
Use of laxatives
Fourteen (7.1%) used laxatives on demand only, 162
(82.2%) used laxatives regularly only and 21 (10.7%)
used laxatives on demand in addition to regular use.
Table 2 gives the dosage schedule of the various laxa-
tives. The most frequently used laxatives were lactulose,
sodium pico sulfate and bisacodyl, used by 124 (63.5%),
41 (21.3%) and 24 (12.2%) respectively. Twenty partici-
pants had incomplete data on the dosage schedule. The
dosage schedules of bisacodyl, senna glycosides, sodium
pico sulphate, macrogols and enemas were usually one
to three times a week.
In subjects without normal bowel function, generally
accepted treatment guidelines were disregarded in two
out of 6 (33%) with hard and lumpy stools who did not
use osmotic laxatives and in 3 out of 3 subjects (100%)
with defecation less than once a week who did not use
prokinetics or contact laxatives. In 27 subjects in need
of manual manoeuvres to facilitate a bowel movement,
24 (89%) did not use enemas and 9 (33%) did not use
osmotically acting laxatives.
197 (74.1%) residents used laxatives 
29 wards with 647 residents 
participated 
13 nursing homes with 31 wards 
participated  
24 nursing homes were invited to 
participate 
11 nursing homes did 
not want to participate  
Two wards did not 
want to participate 
266 residents gave consent to 
participate and had complete data 
381 residents did not 
participate: 
o Informed consent 
was not obtained  
o Did not fulfil 
inclusion criteria 
o Severely ill or dying 
o Missing data on 
bowel function 
116 (58.9%) residents had 
normal bowel function 
81 (41.1%) residents had altered 
bowel function 
69 residents did not use 
laxatives 
Figure 1 The participants in the study.
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Normalization of the bowel function, which was achieved
by 116 (58.9%), did not differ significantly between the
laxative regimes or the potency of the regimens (tables 3
and 4). In subjects with normal bowel function, 113
(97%) had persistent complaints; straining, manual man-
oeuvres to facilitate bowel movements, feeling of incom-
plete bowel movements and feeling of anorectal
Table 1 Characteristics of the participants and a comparison between participants with and without normal bowel
function.
Characteristics All participants
n = 197
Participants with normal bowel
function
n = 116
Participants with
altered bowel function
n=8 1
Statistics
p-value
Age (years) 85.6 (SD 6.9) 85.1 (SD 7.1) 86.4 (SD 6.7) 0.18
Gender - female 74.6 71.6 79.0 0.25
Body mass index (kg/m
2) (n = 183) 24.3 (SD 5.3) 24.9 (SD 5.3) 23.5 (SD 5.2) 0.07
Smoking: Current/Before/Never (n = 193) (%) 7.8%/16.1%/76.2% 10.4%/17.4%/72.2% 3.8%/14.1%/82.1% 0.07
Use of alcohol more than once a month (n =
193)
29 (15.0%) 14 (12.3%) 15 (19.0%) 0.22
Intake of liquids (glass/day) 9.0 (1.0-17.0) 9.0 (3.0-15.0) 8.0 (1.0-17.0) 0.01
Dietary fibre (g/day) (n = 195) 14.5 (3.7-41.0) 14.7 (4.6-41.0) 13.5 (3.7-30.3) 0.15
Katz: Activity of daily living
1 1 (0-6) 1 (0-6) 1 (0-6) 0.31
Mobility: Bedridden/Walk indoors/Walk
outdoors
105(53.3%)/54
(27.4%)/
38(19.3%)
61(52.6%)/28(24.1%)
/27(23.3%)
44(54.3%)/26(32.1%)/11
(13.6%)
0.36
MNA
2 - score (n = 141) 20.0 (8.5-26.0) 20.8 (8.5-26.0) 18.0 (9.5-26.0) 0.05
Consistency of food (n = 196)
Mashed food/Bread without crust/Ordinary
food
35(17.9%)/39(19.9%)
/122(62.2%)
15(12.9%)/20(17.2%)
/81(69.8%)
20(25.0%)/19(23.8%)
/41(51.3%)
0.007
Number of diseases (n = 196) 5.0 (1-15) 5.0 (1-15) 4.0 (0-11) 0.36
Heart diseases (n = 195) 86 (44.1%) 52 (45.2%) 34 (42.5%) 0.77
Thrombo-embolic disease (n = 195) 16 (8.2%) 6 (5.2%) 10 (12.5%) 0.11
Stroke (n = 195) 75 (38.5%) 44 (37.9%) 31 (39.2%) 0.88
Depression/anxiety (n = 196) 98 (50.0%) 65 (56.0%) 33 (41.3%) 0.06
Dementia (n = 196) 104 (53.1%) 58 (50.0%) 46 (57.5%) 0.31
Diabetes (both I and II) (n = 196) 22 (11.2%) 13 (11.2%) 9 (11.3%) 1.00
Parkinson’s disease(n = 196) 11 (5.6%) 5 (4.3%) 3 (7.5%) 0.34
Hypothyroidism (n = 195) 8 (4.1%) 5 (4.3%) 3 (3.8%) 0.84
Rheumatoid arthritis (n = 196) 8 (4.1%) 2 (1.7%) 6 (7.5%) 0.04
Cancer (n = 191) 30 (15.7%) 24 (21.4%) 6 (7.6%) 0.01
Abdominal operation (n = 193) 30 (15.5%) 22 (19.6%) 8 (9.9%) 0.07
Number of drugs 6 (0-20) 6 (0-20) 5(0-17) 0.10
Antithrombotic agents (B01A) 104 (52.8%) 61 (52.6%) 43 (53.1%) 1.00
Iron preparations (B03A) 35 (17.8%) 23 (19.8%) 12 (14.8%) 0.45
Diuretics (C03) 88 (44.7%) 54 (46.6%) 34 (42.0%) 0.56
Calcium channel blockers (C08) 23 (11.7%) 13 (11.2%) 10 (12.3%) 0.83
Thyroid hormones (H03AA) 16 (8.1%) 10 (8.6%) 6 (7.4%) 0.80
Antibiotics (J01) 28 (14.2%) 19 (16.4%) 9 (11.1%) 0.41
NSAID (M01A) 14 (7.1%) 9 (7.8%) 5 (6.2%) 0.67
Opioids (N02A) 24 (12.2%) 14 (12.1%) 10 (12.3%) 1.00
Dopaminergic agents (N04B) 9 (4.6%) 2 (1.7%) 7 (8.6%) 0.02
Benzodiazepin derivatives (N05BA) 46 (21.8%) 32 (27.6%) 14 (13.6%) 0.02
Antidepressants (N06A) 85 (43.1%) 50 (43.1%) 35 (43.2%) 1.00
Drug with anticholinergic effect 15 (7.6%) 8 (6.9%) 7 (8.6%) 0.79
High dose of ≥1 laxatives 71 (40.1%) 41 (40.6%) 30 (39.5%) 1.00
1 Katz - Activity of daily living. (Index 0-6: 0 = Very dependent; 6 = Independent)
2 MNA = Mini nutritional assessment
® (score 0-30: <17 malnourished, 17-23.5 at risk of malnutrition, 24-30 normal nutritional status)
n = number available for the analysis
The results are given as mean (SD), median (range) and number (%). There were no missing values for the use of drugs.
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(28.6%) and 26 (22.5%) respectively.
Predictors for normal bowel function
Table 1 gives the characteristics of participants with and
without normal bowel function and comparisons
between the groups. Low intake of fluids, poor nutri-
tional status, intake of mashed food and use of dopami-
nergic agents were statistically significantly associated
with altered bowel function; and cancer (previous or
present), rheumatoid arthritis and use of benzodiaze-
pines with normal bowel function. Good nutritional sta-
tus, cancer and depression/anxiety were independent
predictors of normal bowel function in the multivariable
analyses (table 5). Neither abnormal biological para-
meters nor the use of drugs with marked anticholinergic
effect was associated with the bowel function.
Discussion
Effect of laxatives
In this study, 81/197 (41%) of residents in nursing homes
treated for constipation did not achieve normalization of
stool frequency and consistency. This was judged as
unsatisfactory, but was at least as good as in clinical trials
reporting 40-85% non-responders [7]. Comparisons are,
however, difficult because the definitions of satisfactory
response vary [7]. The effect did not differ significantly
between the drugs and regimens, and was unrelated to
the assumed potency of the regimens, which supports the
finding from a systematic review that there is no evidence
for the superiority of one laxative to another [19]. Better
understanding of the etiology and pathophysiology of
constipation could allow individual adjustment of the
treatment and improve the success rates [3].
In accordance with others, we found that nearly all
subjects with normalized stool frequency and consis-
tence had persistent and bothersome symptoms such as
straining, feeling of incomplete bowel movements and
anorectal obstruction, and some were in need of manual
manoeuvres to facilitate defecation [3]. In all, this prag-
matic study showed that ordinary treatment of constipa-
tion in elderly is far from desirable.
Choice of laxatives
All laxatives used in this study have been proven to be
superior to placebo [7]. Lactulose was the most fre-
q u e n t l yu s e dl a x a t i v ea n dt h eo n l yo n er e g u l a r l yu s e d
Table 2 Dosage schedules of the laxatives.
Substance ATC-level 5 Dosage schedules Missing data
On demand Regular use standard dose Regular use
high dose
Liquid paraffin A06AA01 1 (11.1%) 5 (55.6%) 2 (22.2%) 1 (11.1%)
Bisacodyl A06AB02 2 (7.7%) 21 (80.8%) 1 (3.8%) 2 (7.7%)
Senna glycosides A06AB06 3 (17.6%) 9 (52.9%) 0 5 (29.4%)
Sodium pico sulphate A06AB08 5 (10.6%) 36 (76.6%) 3 (6.4%) 3 (6.4%)
Ispaghula (psylla seeds) A06AC01 1 (14.3%) - - 6 (85.7%)
Lactulose A06AD11 14 (10.1%) 100 (72.5%) 10 (7.2%) 14 (10.1%)
Macrogol combinations A06AD65 1 (5.9%) 16 (94.1%) 0 0
Docusate sodium A06AG10 0 5 (100.0%) 0 0
Laurilsulfate A06AG11 11 (52.4%) 10 (47.6%) 0 0
The results are given as number of participants with proportion (%) in brackets.
Twenty participants had incomplete data on the dosage of regularly used laxatives, and several participants used more than one drug.
Table 3 Effect of regular use of groups of laxatives
Laxatives Normal bowel
function
n = 108 (59.0%)
Altered bowel
function
n = 75 (41.0%)
Osmotically acting laxatives
only
59 (64.8%) 32 (35.2%)
Contact laxatives only 16 (55.2%) 13 (44.8%)
Bulk only 2 (100.0%) 0 (0%)
Enemas only 2 (66.7%) 1 (33.3%)
Softeners/emollients only 2 (33.3%) 4 (66.7%)
Combination of laxatives 27 (51.9%) 25 (48.1%)
The results are given as number of participants with proportion (%) in
brackets.
There were no significant differences between the effect of the groups of
laxatives (exact chi-square test p = 0.36)
Table 4 Bowel function related to expected efficacy of
the laxative regimen.
Normal bowel
function
n = 116 (59%)
Altered bowel
function
n = 81 (41%)
On demand only 8 (57.1%) 6 (42.9%)
Lactulose or fibre only 52 (66.7%) 26 (33.3%)
One laxative other than
lactulose and fibre
29 (54.7%) 24 (45.3%)
Two or more laxatives 27 (51.9%) 25 (48.1%)
The results are given as number of participants with proportion (%) in
brackets.
There were no significant differences between the groups (exact chi-square p
= 0.34; and linear-by-linear p = 0.16)
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of lactulose, despite the rather high price, depends on
local therapeutic tradition. The drug was for a long time
the only osmotic laxative on the market in Norway, and
was believed to have fewer side effects during long-term
treatment. The definitions of high doses for continuous
treatment has, however, not been defined and was arbi-
trarily chosen [13,14,20-22]. Some new treatment alter-
natives (such as lubiprostone and prucalopride) were
not available, and could perhaps have improved the out-
come for some participants.
Although all regimens are known to be effective, and
that one is not superior to another, tailoring the regi-
mens to the individual subject could probably improve
the outcome. Guidelines propose algorithms for treat-
ment of constipation [7]. Some guidelines differ between
acute and chronic constipation, degrees of constipation,
and different subgroups such as slow transit, normal
transit, anorectal outlet obstruction, constipation in
pregnancy etc.[2,13-15]. In this study, these guidelines
were not in regular use and the treatment was neither
adapted to the cause of constipation nor sufficiently
individualized. All patients were probably given the
same initial treatment, and depending on the effect, the
dose was increased or a new regimen added depending
on local traditions. This explains why a significant pro-
portion of subjects with hard stools did not use osmoti-
cally acting laxatives, why subjects with infrequent
bowel movements did not use prokinetics (which was
not available) or contact laxatives, and why subjects in
need of manual manoeuvres to facilitate a bowel move-
ment did not use enemas or osmotically acting laxatives,
which are recommended treatments for these com-
plaints [2,13-15].
The prescription of laxatives is the physicians’ respon-
sibility, but in daily practice registered nurses often
accomplish this treatment rather independently.
Increased involvement of physicians and tailoring of the
treatment to the individual patient could probably
improve the outcome. The insufficient understanding of
the actual patho-physiology in the individual subject
makes tailoring of the treatment difficult.
Independent predictors for altered bowel function
Numerous factors have been associated with constipa-
tion [1,15,23,24]. In this study, as reported by others,
reduced nutritional status was an independent predictor
of altered bowel function [1,25]. Efforts to achieve opti-
mal nutrition in elderly are of importance for their gen-
eral health and could relieve constipation. Previous or
present cancer and anxiety/depression were associated
with normal bowel function. Except for an association
between mental distress and diarrhoea, these findings
are difficult to interpret and of limited clinical impor-
tance [26,27]. Anticholinergics have been associated
with constipation, but in this study, drugs with marked
anticholinergic effects were not associated with the
effectiveness of laxatives.
Strengths and limitations
This pragmatic study showed the effectiveness of every-
day treatment of constipation in an unselected nursing
home population with inclusion of residents regardless
of cognitive functions and co-morbidities. This study
describes real life, which we think is a strength and a
valuable supplement to the optimal results shown in
well conducted clinical trials with conscious follow up,
perfect adjustment of the treatment regimens and exclu-
sion of many patients. The results in this study corre-
spond well with those in clinical trials [7].
The inclusion of nearly everyone, including frail and
mentally reduced participants, necessarily reduced the
data quality. Information about symptoms were obtained
from the participants themselves (some degree of cogni-
tive reduction was common), their next of kin (some
had limited knowledge about their relatives) and the
nurses (with variable knowledge of the participant and
different clinical judgement). Since bowel functions are
in focus for residents at these ages in nursing homes
a n dt h ei n v e s t i g a t o r si n f o r m e da b o u tt h es t u d ya n dt h e
necessity of correct data, the data quality has been
judged as satisfactory. The participation rate was low
but the characteristics of the participants seem to be
representative for residents in nursing homes.
The use of laxatives might have been imprecisely
registered. Some nursing homes might have had an
uncontrolled use of lactulose, and laxatives in general
were handled more roughly and less accurately than
other drugs and could have been given without
registration.
The pathophysiology of constipation is complex and
the laxatives’ way of action is incompletely understood.
Therefore, factors contributing to constipation and the
Table 5 Independent predictors for altered bowel
function.
Statistics
OR
1 CI
2 p-value
Gender (female) 1.46 0.69 - 3.07 0.32
Age (years) 1.01 0.96 - 1.06 0.67
Cancer disease (previous or present) 0.26 0.09 - 0.71 < 0.01
MNA
3 sum score 0.89 0.81 - 0.97 < 0.01
Anxiety/depression 0.46 0.24 - 0.86 0.02
Stepwise backward logistic regression analyses
1 Odds ratio
2 95% confidence interval
3 Mini Nutritional Assessment
® (score 0-30: <17 malnourished, 17-23.5 at risk
of malnutrition, 24-30 normal nutritional status)
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estimated.
Conclusion
Treatment of constipation in nursing homes was unsa-
tisfactory and independent of treatment regimen. Out of
197 residents, only 116 (59%) achieved normalization of
stool frequency and consistency, and even in this group,
113 (97%) had persistent bothersome symptoms. Focus
on individualized therapy based on pathophysiology and
specific symptoms, more involvement of physicians and
better follow-up, together with use of new laxatives,
could improve the outcome of this common and bother-
some disorder.
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